Announcements Trials
Browse Landscape

Status

Completed 21Active not recruiting 17Terminated 10Recruiting 4Withdrawn 2Unknown 2No longer available 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

veliparib 2tucatinib 1pegilodecakin 1palbociclib 1leronlimab 1iniparib 1glembatumumab vedotin 1Vinorelbine 1Letrozole 1Everolimus 1Cisplatin 1Alpelisib 1Ado-Trastuzumab Emtansine 1AM0010 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Alpelisib × Breast × Clear all
NCT03706573 2021-07-19

Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer

Novartis

No longer available
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡